Open Study of CEP-701 in Patients With Refractory Acute Myeloid Leukemia With FLT-3 Mutation - Contacts and Locations

Home

Open Study of CEP-701 in Patients With Refractory Acute Myeloid Leukemia With FLT-3 Mutation

This study has been completed.

Study NCT00030186. Last updated on January 12, 2006. Information provided by Cephalon

Please refer to this study by its ClinicalTrials.gov identifier: NCT00030186

Locations


United States, Maryland
	Johns Hopkins Oncology Center, Bunting Blaustein Building
	Baltimore, Maryland, United States, 21231

United States, Texas
	The University of Texas, M.D. Anderson Cancer Center
	Houston, Texas, United States, 70030

Sponsors and Collaborators

Cephalon